September 5, 2018 – Pfizer Inc. (NYSE:PFE) today announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough […]
New research presented at this year’s Euroanaesthesia congress in Copenhagen, Denmark shows that hypnosedation is a valuable alternative to conventional […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok